跳至主要内容
临床试验/NCT03927365
NCT03927365暂停不适用

Muco-ciliary Cleansing of Lungs in COPD With and Without a Salt Particle Inhaler

Liita Care ApS2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2018年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
35
试验地点
2
主要终点
Muco-ciliary clearance

研究概览

简要总结

Cross-over trial of the effect of a salt particle inhaler on pulmonary muco-ciliary cleansing in COPD patients as measured by lung scintigraphy.

详细描述

Stable COPD patients will be examined twice with minimum two, maximum 14 days interval. In randomized order the patients will inhale from a salt particle inhaler with (active) or without (placebo) content.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Randomization of a salt particle inhaler devices with (active) or without (placebo) content

入排标准

性别
All
接受健康志愿者

入选标准

  • COPD grade 1, 2 and 3 in stable condition (less than 10% change of FEV1 ratio between investigation visits

排除标准

  • Pregnant or lactating women
  • Patients exposed to radionuclear isotopes within one month
  • Patients under antibiotic treatment
  • Patients with known hyper reactive airways

结局指标

主要结局

Muco-ciliary clearance

时间窗: Activity at time 120 minutes

Retention of inhaled radioactive marker in percentage

次要结局

  • Registering number of coughs(Activity at any time between time zero and 120 minutes)
  • Collection of sputum(Activity at any time between time zero and 120 minutes)
  • Symptoms in the subjects health(Activity at time 120)

研究者

发起方
Liita Care ApS
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验